Interestingly, in active SLE patients, LRs expression in CD38+ B cells (median 36.1% (range: 15.1–47.3)) was significantly higher than that in CD38− B cells (median 10.5% (range: 4.1–31.7)), P < 0.001. The gene discussed is CD38; the disease is systemic lupus erythematosus.